Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for attention-deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo-controlled trial.

Rheims S, Herbillon V, Gaillard S, Mercier C, Villeuve N, Villéga F, Cances C, Castelnau P, Napuri S, de Saint-Martin A, Auvin S, Nguyen The Tich S, Berquin P, de Bellecize J, Milh M, Roy P, Arzimanoglou A, Bodennec J, Bezin L, Kassai B, investigators of the AGPI study group

Open source

DOI: 10.1002/epi4.12892
Published: 2024 Apr
Container: Epilepsia open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/epi4.12892,
  title = {Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for attention-deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo-controlled trial.},
  author = {Rheims S and Herbillon V and Gaillard S and Mercier C and Villeuve N and Villéga F and Cances C and Castelnau P and Napuri S and de Saint-Martin A and Auvin S and Nguyen The Tich S and Berquin P and de Bellecize J and Milh M and Roy P and Arzimanoglou A and Bodennec J and Bezin L and Kassai B and investigators of the AGPI study group},
  year = {2024},
  journal = {Epilepsia open},
  doi = {10.1002/epi4.12892},
  url = {https://doi.org/10.1002/epi4.12892}
}

RIS

TY  - JOUR
TI  - Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for attention-deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo-controlled trial.
AU  - Rheims S
AU  - Herbillon V
AU  - Gaillard S
AU  - Mercier C
AU  - Villeuve N
AU  - Villéga F
AU  - Cances C
AU  - Castelnau P
AU  - Napuri S
AU  - de Saint-Martin A
AU  - Auvin S
AU  - Nguyen The Tich S
AU  - Berquin P
AU  - de Bellecize J
AU  - Milh M
AU  - Roy P
AU  - Arzimanoglou A
AU  - Bodennec J
AU  - Bezin L
AU  - Kassai B
AU  - investigators of the AGPI study group
PY  - 2024
JO  - Epilepsia open
DO  - 10.1002/epi4.12892
UR  - https://doi.org/10.1002/epi4.12892
ER  -

APA

S, R., V, H., S, G., C, M., N, V., F, V., C, C., P, C., S, N., A, D. S., S, A., S, N. T. T., P, B., J, D. B., M, M., P, R., A, A., J, B., L, B., B, K., & group, I. O. T. A. S. (2024). Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for attention-deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo-controlled trial.. Epilepsia open. https://doi.org/10.1002/epi4.12892

Source records

pubmed · retrieved 2026-09-26T18:47:37.383Z